The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells

Cancer immunotherapy using chimeric antigen receptor–armed T (CAR T) cells have been shown to improve outcomes significantly in patients with hematological malignancies. However, cytokine release syndrome (CRS) remains a risk. CRS is characterized by the excessive activation of CAR T cells and macro...

Descripción completa

Detalles Bibliográficos
Autores principales: Futami, Muneyoshi, Suzuki, Keisuke, Kato, Satomi, Ohmae, Saori, Tahara, Yoshio, Nojima, Masanori, Imai, Yoichi, Mimura, Takayuki, Watanabe, Yoshihiro, Tojo, Arinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176125/
https://www.ncbi.nlm.nih.gov/pubmed/32320454
http://dx.doi.org/10.1371/journal.pone.0231896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176125/
https://www.ncbi.nlm.nih.gov/pubmed/32320454
http://dx.doi.org/10.1371/journal.pone.0231896

Ejemplares similares